Ladenburg Thalmann Financial Services’s Axsome Therapeutics AXSM Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$771K	Buy	7,454 +2,654	+55%	+$107K	﹤0.01%	1473
2019 Q3	$97K	Hold	4,800	–	–	﹤0.01%	2955
2019 Q2	$124K	Buy	4,800 +1,400	+41%	+$28.1K	﹤0.01%	2820
2019 Q1	$48K	Buy	3,400 +1,809	+114%	+$16.8K	﹤0.01%	3422
2018 Q4	$4K	Sell	1,591 -1,645	-51%	-$5.41K	﹤0.01%	4661
2018 Q3	$11K	Sell	3,236 -1,740	-35%	-$5.16K	﹤0.01%	4219
2018 Q2	$12K	Hold	4,976	–	–	﹤0.01%	4129
2018 Q1	$12K	Buy	4,976 +4,585	+1,173%	+$13.7K	﹤0.01%	4129
2017 Q4	$2K	Hold	391	–	–	﹤0.01%	4749
2017 Q3	$2K	Hold	391	–	–	﹤0.01%	4643
2017 Q2	$2K	Hold	391	–	–	﹤0.01%	4567
2017 Q1	$2K	Hold	391	–	–	﹤0.01%	4544
2016 Q4	$3K	Hold	391	–	–	﹤0.01%	4395
2016 Q3	$3K	Buy	+391	New	+$2.96K	﹤0.01%	4337

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ladenburg Thalmann Financial Services's AXSM Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Axsome Therapeutics (AXSM) stake by 55% in Q4 2019, buying an estimated $107K and bringing the position to 7,454 shares worth $771K. The position accounts for ﹤0.01% of the portfolio, ranked #1473.

Ladenburg Thalmann Financial Services first reported a position in AXSM in Q3 2016 and has held it in 14 quarters since. 169 funds tracked by Wall St. Rank hold AXSM as of Q4 2019.

Ladenburg Thalmann Financial Services held 7,454 shares of Axsome Therapeutics worth $771K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 2,654 Axsome Therapeutics shares in Q4 2019, an estimated $107K.
Axsome Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1473 holding.
Ladenburg Thalmann Financial Services first reported a position in Axsome Therapeutics in Q3 2016 and has held it in 14 quarters since.
169 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.